Compounds > dansylarginine n-(3-ethyl-1,5-pentanediyl)amide
Page last updated: 2024-09-03

dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and Blood Clot

dansylarginine n-(3-ethyl-1,5-pentanediyl)amide has been researched along with Blood Clot in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brotherton, AA; Czervionke, RL; Fry, GL; Haycraft, DL; Hoak, JC1
Bastida, E; Escolar, G; Jamieson, GA; Ordinas, A1

Other Studies

2 other study(ies) available for dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and Blood Clot

ArticleYear
Role of the vascular endothelium.
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 1981, Aug-18, Volume: 294, Issue:1072

    Topics: Animals; Arginine; Arteries; Aspirin; Blood Platelets; Cattle; Cells, Cultured; Dansyl Compounds; Endothelium; Epoprostenol; Platelet Adhesiveness; Platelet Aggregation; Prostaglandins; Thrombin; Thrombosis

1981
Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis.
    Blood, 1984, Volume: 64, Issue:1

    Topics: Antibodies; Arginine; Blood Coagulation; Cell Line; Centrifugation, Density Gradient; Dansyl Compounds; Glioma; Humans; Neoplastic Stem Cells; Perfusion; Platelet Aggregation; Thromboplastin; Thrombosis

1984